Literature DB >> 16103678

Historical descriptions of multiple sclerosis.

J M S Pearce1.   

Abstract

Modern understanding of multiple sclerosis is firmly founded on the labours of many neuroscientists of the last two centuries. The cost of the disease to its victims is nowhere better displayed than in their personal accounts of their illnesses. Two figures stand out: the high-born aristocrat, Augustus D'Este and his diaries of the early 19th century and the courageous if histrionic Bruce Frederick Cummings in the early 20th century. This paper cannot do justice to their major contributions, but seeks to summarise them to give the flavour of their symptoms, disabilities and the way they were regarded by doctors and the people at large. The early medical studies of Carswell, Cruveilhier, Charcot and many others are briefly reviewed as relevant settings to these personal histories. (c) 2005 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2005        PMID: 16103678     DOI: 10.1159/000087387

Source DB:  PubMed          Journal:  Eur Neurol        ISSN: 0014-3022            Impact factor:   1.710


  9 in total

1.  Jean-Martin Charcot: the father of neurology.

Authors:  David R Kumar; Florence Aslinia; Steven H Yale; Joseph J Mazza
Journal:  Clin Med Res       Date:  2010-08-25

Review 2.  An Update on the Measurement of Motor Cerebellar Dysfunction in Multiple Sclerosis.

Authors:  Katherine Hope Kenyon; Frederique Boonstra; Gustavo Noffs; Helmut Butzkueven; Adam P Vogel; Scott Kolbe; Anneke van der Walt
Journal:  Cerebellum       Date:  2022-06-27       Impact factor: 3.648

Review 3.  The "Treatise on the spleen and stomach" (Pí Wèi Lùn) as the first record of multiple sclerosis in the medical literature - A hypothesis based on the analysis of clinical presentation and herbal medicine.

Authors:  Andréa D Fuzimoto; Francesco Brigo
Journal:  J Tradit Complement Med       Date:  2020-03-02

4.  Cyclin-dependent kinase 5 activity is required for T cell activation and induction of experimental autoimmune encephalomyelitis.

Authors:  Tej K Pareek; Eric Lam; Xiaojing Zheng; David Askew; Ashok B Kulkarni; Mark R Chance; Alex Y Huang; Kenneth R Cooke; John J Letterio
Journal:  J Exp Med       Date:  2010-10-11       Impact factor: 14.307

Review 5.  Using EAE to better understand principles of immune function and autoimmune pathology.

Authors:  Manu Rangachari; Vijay K Kuchroo
Journal:  J Autoimmun       Date:  2013-07-09       Impact factor: 7.094

Review 6.  Treating primary-progressive multiple sclerosis: potential of ocrelizumab and review of B-cell therapies.

Authors:  Jenny J Feng; Daniel Ontaneda
Journal:  Degener Neurol Neuromuscul Dis       Date:  2017-02-01

7.  ThalaMS: New Evidence Linking Epilepsy, Multiple Sclerosis, and the Thalamus.

Authors:  Mark P Beenhakker
Journal:  Epilepsy Curr       Date:  2022-05-06       Impact factor: 7.872

8.  Oral Health Status and Multiple Sclerosis: Classic and Non-Classic Manifestations-Case Report.

Authors:  Céu Costa; Hugo Santiago; Sofia Pereira; Ana Rita Castro; Sandra Clara Soares
Journal:  Diseases       Date:  2022-09-09

Review 9.  The Therapeutic Potential of the Ketogenic Diet in Treating Progressive Multiple Sclerosis.

Authors:  Mithu Storoni; Gordon T Plant
Journal:  Mult Scler Int       Date:  2015-12-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.